O1–11–05: Pharmacological inhibition of the beta‐amyloid and apolipoprotein E interaction ameliorates Alzheimer's pathology in APPSW/PS1dE9 / APOE‐ε2‐TR and APPSW/PS1dE9 / APOE‐ε4‐TR mice. (1st July 2013)